Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. FTNT
4. QCOM
5. ARM
6. SBUX
7. TENB
8. CVNA
9. CMG
10. EQIX

Go back to Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
(NASDAQ: LEXX) Delayed: 0.44 -0.09 (16.98%)
Previous Close $0.53    52 Week High $ 
Open $0.52    52 Week Low $ 
Day High $0.55    P/E N/A 
Day Low $0.43    EPS $ 
Volume 284,987